either serum starvation of or DNA damage (10 Gy) to confluent G1 CV-1 cells, suggesting that the presence of this complex is not a G1 checkpoint response (data not shown).
Partial peptide mapping was performed on p300/ CBP-associated p50 from multiple cell types, epithelial and fibroblast, human and rodent (IMR90, 293, U2-OS, NIH3T3 [mouse], and MvLu [mink]), all growing as monolayers. p50, characterized by a similar basic digestion pattern, was detected as a p300 and/or CBP binding protein in all cell lines tested ( Figure 1D ; data not shown). It also coprecipitated with p300/CBP in IPs generated with two different p300/CBP mAbs, each of which reacts with a unique epitope (AC240 and RW144; data not shown). Thus, it appears that the p50 primary structure is well conserved among mammals, as is its ability to interact with p300 and/or CBP.
p50 Is SYT, a 45-kDa Proto-Oncoprotein
In an effort to identify p50, we purified it using p300 coimmunoprecipitation. After copper staining, the coprecipitated p50 band was excised and subjected to microsequencing. The sequence of the dominant peak in the tryptic peptide profile was GKGEITPAAIQK, which by database analysis is present in the sequence of SYT, a known human protein. SYT was originally identified as the 5Ј segment of a fusion protein, SYT-SSX, a product of chromosomal translocation t(X;18)(p11.2;q11.2) involving two genes, SYT on chromosome 18 and SSX on the X chromosome (Clark et al., 1994). This fusion gene exists in Ͼ90% of synovial sarcomas, implying clonal SYT. The results revealed that p50, which coimand 3, respectively), were each excised from the gel and subjected munoprecipitateded with p300/CBP using p300 antito partial V8 protease digest analysis, as described in Experimental body, was successfully re-immunoprecipitated by B24, Procedures. except when the antibody was preincubated with GST-SYT ( Figure 2C ). By contrast, it did re-immunoprecipitate when the antibody was preincubated with unfused GST. immunoprecipitate p300/CBP or p50 (data not shown).
Moreover, in keeping with independent results obtained Upon boiling a similar IP generated in 500 mM NaClupon analysis of metabolically labeled p300/p50 comcontaining buffer, we found that p50, unlike p300/CBP, plexes in confluent versus sparse G1 CV-1 cells (data failed to reprecipitate with p300/CBP antibody, implying not shown), the endogenous SYT-p300/CBP complex that it is a p300/CBP-associated protein as opposed to (detected by anti-SYT IP, using B24, and immunoblota cross-reactive one ( Figure 1B) . ting with p300/CBP antibody) was also observed in conFurther analysis of confluent G1 versus synchronized fluent and was greatly diminished in sparse cells (Figure cycling cells was performed, again in search of p300/ 2D, cf. lanes 3 and 12). Thus, complexes of SYT with CBP-p50 complexes ( Figure 1C ). The data revealed that p300 and/or CBP accumulate in confluent but not sparse p50-containing complexes were detected in G1 but that G1 cells. Lack of SYT/p300 complex formation was not they were difficult to detect at the beginning of S phase associated with a lack of expression of SYT during the or for up to 7 hr after release from a hydroxyurea block.
various cell cycle intervals that were studied, as reBy 7 hr after hydroxyurea release, the synchronized culflected in a Western blot for SYT protein performed ture was largely composed of G2/M cells. Furthermore, on standardized quantities of the relevant cell extracts analyzed in Figure 2D (lower panel). the interaction of p50 with p300/CBP persisted after 
SYT Is a Nuclear Protein That Specifically
E1A plus ras were uniformly unsuccessful. Therefore, given the selective association of SYT with p300 in conAssociates with p300 p300 and CBP are highly homologous nuclear proteins, tact-inhibited cells, we asked whether SYT/p300 complex formation was an indicator of the state of cell adhebut in vivo genetic studies reveal that they are not identical in their repertoire of functional properties (Yao et al., sion to a solid substratum and/or matrix. In this regard, confluent, contact-inhibited CV-1 cells were detached 1998; Kung et al., 2000) . To determine whether one, the other, or both of them interact with SYT in vivo, from a tissue culture dish after brief treatment with EDTA. They were washed with divalent cation-free salt endogenous SYT was immunoprecipitated from CV-1 cells, and the identity of its p300/CBP coprecipitating solution, resuspended in growth medium, and then allowed to rotate at 37ЊC on a mechanical wheel for inpartner was sought by blotting with p300-and CBPspecific mAbs. The analysis revealed the presence of creasing time periods to prevent them from reattaching. At the indicated time points, the abundance of SYT/ p300 ( Figure 3A p300/SYT complexes and the state of cell spreading, To search for the intracellular location of endogenous an adhesion-dependent process, we exposed confluent SYT, cells were immunostained with the aforementioned CV-1 cells for a brief time to divalent cation-free buffer affinity-purified SYT antibody (B24). The result was or buffer containing EGTA. Both conditions cause cells strong nuclear fluorescence, with no signal arising when to round up ( Figure 4C ) without becoming detached. preimmune serum was tested ( Figure 3C ). An HA antiSubsequent replenishment with normal, serum-conbody yielded a similar pattern in cells transfected with taining medium allowed the cells to respread normally HA-SYT. Finally, upon biochemical cell fractionation, ( Figure 4C ). The effect of these various conditions on the both total SYT and the SYT/p300 complexes were deabundance of endogenous SYT/p300 complexes was tected only in the nuclear fraction (data not shown).
analyzed by anti-SYT co-IP and anti-p300 immunoblot. Thus, like p300, SYT and SYT/p300 complexes appear When compared with adherent cells ( Figure 4B , lane 1), to be primarily nuclear elements. a brief exposure to divalent cation-free salt solution or EGTA led to cell rounding ( Figure 4C ) and simultaneous disappearance of SYT/p300 complexes ( Figure 4B , The Endogenous SYT/p300 Interaction Is lanes 2-4). When the rounded cells were allowed to Dynamically Regulated by the State respread ( Figure 4C ), SYT/p300 complexes reappeared of Cell Adhesion ( Figure 4B, lanes 5-7) . When newly respread cells were reEfforts to discern an effect of wild-type or mutant SYT on cell growth, proliferation rate, or transformation by incubated with divalent cation-free solution, cells rounded ability to interact with in vitro-translated, full-length SYT ( Figure 5A ). The data imply that there are two specific segments of p300 with affinity for SYT. One contains the C/H1 and the other the C/H3 domain ( Figure 5A , lanes 1 and 3, and 5 and 6, respectively). By contrast, under the conditions employed, the C/H2 domain and its flanking region failed to bind SYT ( Figure 5A , lane 4). Therefore, there may be multiple, specific modes of contact between p300 and SYT. HA-tagged N-and C-terminal SYT deletion mutants were created ( Figure 5B ). When these cDNAs were expressed at similar levels (data not shown) in U2-0S cells, mutants lacking at least 43 residues from the extreme SYT N terminus failed to bind to p300, as defined by anti-SYT co-IP. By contrast, both small and more extensive deletions from the C terminus did not affect this interaction ( Figure 5B ; data not shown).
Effect of SYT Mutants on Cell Adhesion
Given the existence of a relationship between the abundance of SYT/p300 complexes and the state of cell adhesion, we asked whether overproduction of one or more SYT mutants affects the adhesive state of the relevant transfected cells. Thus, CV-1 cells were cotransfected with expression vectors encoding GFP and either HA-tagged wild-type SYT or one of the aforementioned HA-tagged SYT dl mutants ( Figure 5B ). Transfected cells were assayed for their ability to adhere to a fibronectin-coated surface, as compared with a poly-L-lysine coated one (poly-L-lysine is a nonspecific adhesive surface). Adhesion was measured as the ratio of the num- on cell adhesion, implying a normal contribution to this process by endogenous SYT. Similar results were obtained in NIH3T3 cells (data not shown), indicating that up again, and p300/SYT complexes again diminished in SYT function may affect cell adhesion in cultured, imabundance, reappearing again after subsequent remortalized cells of both epithelial and fibroblast, as well spreading ( Figure 4B , lanes 8 and 9, respectively). Reacas primate and murine origin. cumulation of SYT/p300 complexes occurred in a time-SYT34 and 35, which were inert in these assays, candependent manner during the period of respreading not bind to p300, suggesting that the expression of dom-(data not shown). Neither the cellular abundance of SYT inant interfering activity by the relevant mutants requires or p300 (determined by Western blotting with monospestable p300 binding. This, in turn, suggests that the cific antibodies) nor their nuclear localization (detercontribution to cell adhesion made by SYT requires its mined by immunofluorescence) changed during the interaction with p300. In this regard, it is worth noting course of the experiment (data not shown). Thus, there that SYT28, which lacks the eight C-terminal residues is a dynamic relationship between SYT/p300 complex of the protein, is the deletion mutation of SYT most formation and the state of cell adhesion/spreading, commonly detected in the SYT/SSX tumor fusion prodwhich is independent of the abundance of either protein.
uct (see Introduction).
Structure-Function Relationships Underlying Effect of p300 Gene Dosage upon Embryonic the SYT/p300 Interaction Cell Adhesion Properties To identify the regions of binding between SYT and
To assess the putative role of p300 in cell adhesion control, we performed experiments on embryonic cells p300, a series of p300 dl mutants were tested for their freshly prepared from wild-type E9.5 mouse embryos To determine whether this relationship extends to cell adhesive properties and, if so, whether the effect is and littermates that were heterozygous null for p300 or CBP. Previous studies have shown that heterozygosity p300-specific-in keeping with the absence of a CBP interaction with SYT-we analyzed the adhesive properat the p300 locus or CBP locus is accompanied by haploinsufficiency for certain functions (Giles et taining SYT-associated proteins rather than SYT derivawt, wild type.
tives. There was no hint of SYT tyrosine phosphorylation or of any putative coprecipitating, p-tyr-containing partner in sparse cell extracts ( Figure 6C, lane 5) , although the These cells were freshly derived from embryos of the same genetic background (C57BL/6). Homozygous null level of endogenous SYT was similar to that in confluent cells. These data imply that when SYT/p300 complexes cells were not analyzed here because they are severely defective in proliferation and undergo early growth arform in contact-inhibited cells, SYT becomes tyrosinephosphorylated and interacts with at least two new partrest (Yao et al., 1998). The question was whether freshly explanted, unmanipulated primary cells, taken from ners that are also tyrosine-phosphorylated.
In an effort to detect downstream targets of SYT/p300 wild-type E9.5 embryos and from E9.5 embryos lacking one copy of the CBP or p300 gene, were or were not complexes, we transfected cells with SYT DN mutants and analyzed the abundance of the primary fibronectin defective in adhesion behavior.
Cells from freshly dissected embryos were assayed receptor, ␤1 integrin, as well as focal adhesion-associated proteins known to be active in promoting cell for their ability to adhere to fibronectin-coated surfaces, as described above. Other aliquots of these test cells adhesion. In such cells, which are defective in cell adhesion, there was no detectable change in the level or were independently genotyped by a second operator. When the double-blinded genotype and cell adhesion tyrosine phosphorylation profile of ␤1 integrin, focal adhesion kinase, p130cas, or paxillin ( Figure 6D ; data not results were analyzed together, it was apparent that in comparison with wild-type and CBPϩ/Ϫ MECs, MECs shown). In contrast, when compared with vector-transfected cells, the extent of ␤1 integrin receptor activation from multiple embryos with a p300ϩ/Ϫ genotype were overtly and repeatedly defective in adhesion (Table 1) .
by manganese (Bazzoni et al., 1998) was significantly inhibited in the presence of either SYT DN mutant (see Thus, it appears that the p300 (as opposed to the CBP) gene dose has a major effect on cell adhesive properties, Figure 6E for an example of an effect of SYT 29). Activation was measured by the ability of the receptor to adopt in keeping with the fact that p300 and not CBP is an SYT binding partner. These findings reinforce the hypothesis an activation-specific conformation that allows it to interact with a specific, anti-␤1 integrin mAb (Bazzoni et that SYT/p300 complexes are active controlling elements in fibronectin adhesion function. al., 1995). When quantitated by comparison with cells synthesizing comparable quantities of ectopically expressed wild-type SYT, there was an ‫%44ف‬ reduction Insights into the Mechanism Linking SYT/p300 in 9EG7 reactivity of cells synthesizing SYT 29 and an Complexes to Cell Adhesion Control ‫%42ف‬ reduction in cells synthesizing SYT 28 ( Figure 6E ; To determine whether the effect of SYT/p300 complex see also Figure 5B for mutant structures). To control for on cell adhesion is dependent on active transcription, cell viability and gross integrity, we also analyzed all we incubated CV-1 cells with enough actinomycin D cells after plating on a poly-L-lysine surface to which all (5g/ml for 3 hr) to block transcription effectively. Subadhered with equivalent, high efficiency (Ͼ90%). Taken sequently we allowed the cells to round up on a culture together, these results imply that at least one participant dish and then to respread in complete, drug-containing in the interruption of adhesion by the relevant SYT DN medium, as described above. Another aliquot was mutants is inadequate ␤1 integrin/fibronectin receptor treated similarly in the absence of the drug. As shown function. in Figure 6A , the cells respread rapidly (i.e., in Ͻ30 min) and without apparent difficulty with or without the drug, Discussion and SYT/p300 complexes accumulated normally in the drug-treated cells ( Figure 6B function of p300. It and a known human proto-oncoprotein, SYT, interact in the nucleus. Formation of SYT/p300 The lack of adhesion dependence on transcription and the speed with which SYT/p300 complexes recomplexes was confined to G1-arrested, confluent cells, was absent in sparse G1 cells, and appears to translate formed upon cell spreading led us to speculate that the EcoRI. After exposure to T4 polynucleotide kinase, each product and a DNA fragment encoding an HA epitope tag (obtained by anmin at 37ЊC. After two washes with serum-free DME, embryonic cells were ready for analysis in the adhesion assay, described above. nealing the 5Ј primer JE-23, 5Ј-AGCTTACCATGGCCTACCCCTAC GACGTGCCCGACTACGCCTCCCTCCC-3Ј, to the 3Ј primer JE-24, 5Ј-GGGAGGGAGGCGTAGTCGGGCACGTCGTAGGGGTAGGCCAT ␤1 Integrin Activation Assay GGTA-3Ј) were ligated between the HindIII and the EcoRI sites of The ␤1 integrin assay was performed as previously described (Bazthe expression vector pcDNA3 (Invitrogen), which contains a rabbit zoni et al., 1995) with certain modifications. CV-1 cells were trans-␤-globin intron to optimize expression (Scully et al., 1997) .
S-labeled CV-1 cell extract was boiled and reprecipitated with B24 (SYT) (lanes 1 and 4), with 4G10 (anti-phosphotyrosine) (lanes 2 and 5), or with PB (preimmune serum) (lane 3). (D) A 9EG7 (␤1 integrin) IP of lysates of CD19-selected CV-1 cells transfected with CD19 expression vector and wild-type SYT (lane S) or the DN mutants SYT28 and SYT29 (lanes 28 and 29, respectively). (E) Representative
fected with various HA-tagged SYT species (30 g) and, in some For in vitro translation experiments, SYT was inserted alone into cases, with a CD19 expression vector ‫4ف(‬ g), using Superfect pcDNA3 between a blunt-ended (with Klenow fragment and dNTPs) (Qiagen). When CD19 was co-expressed, transfectants were purified HindIII site and its EcoRI site. In vitro-translated SYT was assayed on CD19 beads (Dynal). At 48 hr after plating in complete medium, for binding to the various GST fusion proteins (Lee et al., 1995) , as they were detached by brief trypsinization, allowed to recover in previously described (Grossman et al., 1998) . complete medium, and washed once with PBS and once with TBS buffer (24 mM Tris-HCl [pH 7.4], 137 mM NaCl, and 2.7 mM KCl).
Immunofluorescence
The cells were then incubated for 30 min at 37ЊC in TBS buffer The affinity-purified, SYT-specific polyclonal antibody B24 and the containing 5% BSA and 0.02% sodium azide, with or without 2 mM preimmune serum (from the rabbit that generated B24) were used MnCl 2 . This was followed by incubation on ice for 45 min in the at a 1:200 dilution. HA-specific mAb (12CA5) was used at a 1:15 presence of 2 g/ml 9EG7 antibody (anti ␤1; Pharmingen). After dilution. Immunofluorescent analysis of endogenous and transthree washes with TBS with 1% BSA, a rhodamine-labeled second fected SYT was performed as previously described (Grossman et anti-mouse Ig antibody (Jackson Laboratories) was added at 1:200 al., 1998). Rhodamine phalloidin staining was performed, following on ice for 45 min, followed by three washes with TBS. Binding of the manufacturer's instructions (Molecular Probes).
9EG7 to the ␤1 integrin activation epitope on transfected cells was visualized after they were allowed to adhere to poly-L-lysine-coated cover slips for 30 to 0 min, followed by fixation and staining with Cell Detachment fluorescein-conjugated anti-HA antibodies, as described above. 
